Baroda BNP Paribas Health & Wellness IDCW Reinvest Direct Plan
SIP amount
Min. ₹500
Lumpsum amount
Min. ₹1,000

Baroda BNP Paribas Health & Wellness IDCW Reinvest Direct Plan

NAV
₹9.6932
+0.02%
(20 Nov)
AUM
621 Cr
TER
0.43%
Risk
Very High Risk
Insights
Total Expense Ratio (TER) is in the bottom 25% of comparable funds
In beta. Send feedback here.
Compare with other fund
1Y
+12.3%
+12.3%
+12.2%
+12.2%
NA
3Y
+30.8%
+30.8%
+31.1%
+31.1%
NA
5Y
+32.7%
+32.7%
+31.2%
+31.2%
NA
ALL
+12.3%
+12.3%
+16.9%
+16.9%
-3.1%
VOL
20.1%
20.1%
20.1%
20.1%
9.7%
TER
0.8%
0.8%
0.9%
0.9%
0.4%
AUM
₹5,714 Cr
₹5,714 Cr
₹1,466 Cr
₹1,466 Cr
₹621 Cr
INFO
0.61
0.61
0.84
0.84
-0.32
See fund holdings as of 31st Oct
Top holdings
Sun Pharmaceuticals Industries Ltd
9.3%
Mankind Pharma Ltd
7.3%
Divi's Laboratories Ltd
7.1%
Apollo Hospitals Enterprise Ltd
6.2%
Max Healthcare Institute Ltd Ordinary Shares
5.5%
Cipla Ltd
5.4%
Aster DM Healthcare Ltd Ordinary Shares
4.9%
Clearing Corporation Of India Ltd
4.7%
Abbott India Ltd
4.6%
AstraZeneca Pharma India Ltd
4.0%
Top industry exposure
Healthcare
92.8%
Financial Services
2.8%
Other information
Minimum SIP
₹500
Minimum lumpsum
₹1,000
Additional lumpsum
₹1,000
Portfolio turnover
17%
Lock-in period
-
Exit load
• 1% for redemption within 365 days
Fund objective
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.
Fund manager(s)
Sanjay Chawla

FAQs